In the news
Explore data for context of the war in Ukraine

Coronavirus (COVID-19) Vaccinations

Our international COVID-19 vaccination dataset is updated each morning (London time), with data up to the previous day.
Reuse our work freelyCite this research

Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. Population estimates for per-capita metrics are based on the United Nations World Population Prospects. Income groups are based on the World Bank classification. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

Open the Data Explorer in a new tab. Select a group of countries at once: all European countries, 30 largest countries; European Union; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.
Our work belongs to everyone
Cite our vaccination data
Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

Country-by-country data on vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several if you want to compare countries. All charts on this page will then show data for the countries that you selected.

What share of the population has received at least one dose, and completed the initial vaccination protocol?

The following charts show the breakdown of people vaccinated, between those who have received only their first vaccine dose, and those who have completed the initial vaccination protocol (2 doses for most vaccines, 1 or 3 for a few manufacturers).

How many vaccine doses have been administered in total?

The following map and chart show the number of vaccine doses administered per 100 people within a given population. All doses, including boosters, are counted individually.

How many vaccine doses have been administered in the last 12 months?

The following chart shows, for each date, the total number of vaccine doses administered in the 12 months preceding that date. This is given per 100 people in the population. All doses, including boosters, are counted individually.

What share of the population has received at least one dose of vaccine?

The following chart shows the share of the total population that has received at least one dose of vaccine. This may not equal the share with a complete initial protocol if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number with a complete initial protocol if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has completed the initial vaccination protocol?

The following chart shows the share of the total population that has been completed the initial vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

Total number of people who have completed the initial vaccination protocol

The following chart shows the total number of people that have completed the initial vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

How many vaccine booster doses have been administered?

The following charts show the number of booster doses administered. Booster doses are doses administered beyond those prescribed by the original vaccination protocol — for example, a third dose of Pfizer/BioNTech vaccine, or a second dose of Johnson & Johnson vaccine.

Vaccinations by age

The following charts provide data on the share of people that have been vaccinated against by age group. This is provided as three metrics: the share that has received at least one dose; the share that has completed the initial protocol; and the share that is only partially vaccinated.

This data is only available for countries that report the breakdown of doses administered by first and second doses by age.

Share that have received at least one dose by age

The following chart shows the share of the population in each age group that has received at least one dose. This metric includes those that are partly vaccinated or have completed the initial protocol.

Share that have completed the initial protocol by age

The following chart shows the share of the population in each age group that has completed the initial protocol.

Share that have received a booster dose by age

The following chart shows the share of the population in each age group that has received a booster dose.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer. This is only available for a select number of countries that report the necessary data.

How many doses are administered daily?

Daily number of doses administered per 100 people

The following chart shows the daily number of doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of doses administered

How many doses have been donated by each country?

These charts show the cumulative number of doses donated to the COVAX initiative by different countries, broken down by whether the donations have only been announced, actually donated, or delivered to the recipients. This is only available for a select number of countries for which the COVID-19 Task Force reports the necessary data.

The three following charts show the number of doses donated, adjusted for:

  1. The population of the donating country;
  2. The GDP of the donating country;
  3. The number of doses administered by the donating country to its own population.

COVID-19 Vaccines Global Access (COVAX)

COVAX is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that only policies on the availability of vaccinations are tracked. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; we at Our World in Data don’t track policy responses ourselves and we don’t make additions to the tracker’s dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccination

Source information country by country

You can download the full dataset alongside the detailed sources on GitHub.

Vaccination against COVID-19 has now started in 218 locations.

LocationSourceLast observation dateVaccines
AfghanistanWorld Health OrganizationMar. 6, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
AlbaniaMinistry of HealthMar. 7, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
AlgeriaWorld Health OrganizationMar. 10, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
AndorraWorld Health OrganizationFeb. 13, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AngolaWorld Health OrganizationMar. 10, 2022Oxford/AstraZeneca
AnguillaWorld Health OrganizationMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Antigua and BarbudaMinistry of HealthMar. 1, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
ArgentinaMinistry of HealthMar. 10, 2022CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
ArmeniaWorld Health OrganizationFeb. 27, 2022Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
ArubaGovernment of ArubaMar. 10, 2022Pfizer/BioNTech
AustraliaGovernment of Australia via CovidBaseAUMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AustriaMinistry of HealthMar. 8, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
AzerbaijanGovernment of AzerbaijanMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BahamasPan American Health OrganizationMar. 9, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
BahrainMinistry of HealthFeb. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
BangladeshDirectorate General of Health ServicesMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
BarbadosMinistry of HealthMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BelarusWorld Health OrganizationFeb. 20, 2022Sinopharm/Beijing, Sputnik V
BelgiumSciensanoMar. 8, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeWorld Health OrganizationMar. 4, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BeninMinistry of HealthFeb. 22, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BermudaPan American Health OrganizationMar. 4, 2022Oxford/AstraZeneca, Pfizer/BioNTech
BhutanWorld Health OrganizationFeb. 27, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BoliviaMinistry of Health via https://www.boligrafica.com/Mar. 7, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Bonaire Sint Eustatius and SabaWorld Health OrganizationSep. 1, 2021Moderna, Pfizer/BioNTech
Bosnia and HerzegovinaWorld Health OrganizationJan. 29, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BotswanaAfrica Centres for Disease Control and PreventionMar. 10, 2022Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BrazilState governments via coronavirusbra1.github.ioMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
British Virgin IslandsWorld Health OrganizationFeb. 25, 2022Johnson&Johnson, Oxford/AstraZeneca
BruneiWorld Health OrganizationFeb. 25, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BulgariaMinistry of HealthMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Burkina FasoWorld Health OrganizationMar. 6, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
BurundiWorld Health OrganizationMar. 4, 2022Sinopharm/Beijing
CambodiaMinistry of HealthMar. 8, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
CameroonWorld Health OrganizationMar. 1, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
CanadaOfficial data from provinces via covid19tracker.caMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeWorld Health OrganizationMar. 5, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Cayman IslandsWorld Health OrganizationFeb. 25, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Central African RepublicAfrica Centres for Disease Control and PreventionMar. 4, 2022Covaxin, Oxford/AstraZeneca
ChadAfrica Centres for Disease Control and PreventionFeb. 18, 2022Sinopharm/Beijing
ChileMinistry of Health, via Ministry of Science GitHub repositoryMar. 8, 2022CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionMar. 10, 2022CanSino, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001
ColombiaMinistry of HealthMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ComorosWorld Health OrganizationMar. 4, 2022Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
CongoAfrica Centres for Disease Control and PreventionFeb. 17, 2022Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Cook IslandsSPC Public Health DivisionMar. 7, 2022Pfizer/BioNTech
Costa RicaCosta Rican Social Security FundMar. 7, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Cote d’IvoireWorld Health OrganizationMar. 5, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
CroatiaMinistry of HealthMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CubaMinistry of HealthMar. 8, 2022Abdala, Soberana Plus, Soberana02
CuracaoGovernment of CuracaoMar. 10, 2022Moderna, Pfizer/BioNTech
CyprusMinistry of HealthFeb. 26, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CzechiaMinistry of HealthMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
Democratic Republic of CongoWorld Health OrganizationFeb. 28, 2022Oxford/AstraZeneca
DenmarkStatens Serum InstituteMar. 9, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
DjiboutiWorld Health OrganizationFeb. 26, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
DominicaPan American Health OrganizationMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Dominican RepublicMinistry of Public HealthMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EcuadorGovernment of Ecuador via EcuacovidMar. 8, 2022CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EgyptWorld Health OrganizationMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
El SalvadorMinistry of HealthFeb. 28, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EnglandGovernment of the United KingdomMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaMinistry of HealthMar. 5, 2022Sinopharm/Beijing
EstoniaNational Health BoardMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniWorld Health OrganizationFeb. 21, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
EthiopiaWorld Health OrganizationMar. 9, 2022Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
Faeroe IslandsGovernment of the Faeroe IslandsFeb. 18, 2022Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 14, 2021Oxford/AstraZeneca
FijiSPC Public Health DivisionMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FinlandFinnish Institute for Health and WelfareMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
French PolynesiaSPC Public Health DivisionMar. 7, 2022Johnson&Johnson, Pfizer/BioNTech
GabonAfrica Centres for Disease Control and PreventionMar. 10, 2022Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
GambiaAfrica Centres for Disease Control and PreventionFeb. 17, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
GeorgiaNational Center for Disease Control and Public HealthMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
GermanyRobert Koch InstitutMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
GhanaWorld Health OrganizationMar. 10, 2022Oxford/AstraZeneca, Sputnik V
GibraltarGovernment of GibraltarMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech
GreeceMinistry of HealthMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandMar. 7, 2022Moderna
GrenadaWorld Health OrganizationMar. 2, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
GuatemalaMinistry of HealthMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
GuernseyGovernment of GuernseyMar. 7, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencyFeb. 27, 2022Sputnik V
Guinea-BissauWorld Health OrganizationMar. 6, 2022Oxford/AstraZeneca, Sinopharm/Beijing
GuyanaMinistry of HealthMar. 10, 2022Oxford/AstraZeneca, Sputnik V
HaitiPan American Health OrganizationMar. 9, 2022Johnson&Johnson, Moderna
HondurasWorld Health OrganizationFeb. 25, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
Hong KongFood and Health BureauMar. 6, 2022Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthMar. 8, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaGovernment of IndiaMar. 10, 2022Covaxin, Oxford/AstraZeneca, Sputnik V
IndonesiaGovernment of IndonesiaMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
IranWorld Health OrganizationMar. 10, 2022COVIran Barekat, Covaxin, FAKHRAVAC, Oxford/AstraZeneca, Razi Cov Pars, Sinopharm/Beijing, Soberana02, SpikoGen, Sputnik V
IraqWorld Health OrganizationMar. 5, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IrelandHeath Service ExecutiveMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Israel (see FAQ)Government of IsraelMar. 10, 2022Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
JamaicaMinistry of HealthMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JapanPrime Minister’s OfficeMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JerseyGovernment of JerseyMar. 6, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JordanWorld Health OrganizationMar. 2, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
KazakhstanGovernment of KazakhstanMar. 10, 2022QazVac, Sinopharm/Beijing, Sputnik V
KenyaMinistry of HealthMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
KiribatiSPC Public Health DivisionMar. 7, 2022Oxford/AstraZeneca
KosovoMinistry of HealthMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech
KuwaitWorld Health OrganizationMar. 6, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
KyrgyzstanMinistry of HealthMar. 10, 2022Sinopharm/Beijing, Sputnik V
LaosWorld Health OrganizationMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
LatviaNational Health ServiceMar. 9, 2022Johnson&Johnson, Moderna, Novavax, Pfizer/BioNTech
LebanonGovernment of LebanonMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
LesothoWorld Health OrganizationMar. 4, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
LiberiaWorld Health OrganizationFeb. 17, 2022Oxford/AstraZeneca
LibyaWorld Health OrganizationMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
LiechtensteinFederal Office of Public HealthMar. 9, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
LithuaniaMinistry of HealthMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgMar. 5, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoMar. 10, 2022Pfizer/BioNTech, Sinopharm/Beijing
MadagascarWorld Health OrganizationFeb. 28, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MalawiWorld Health OrganizationFeb. 27, 2022Johnson&Johnson, Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaMar. 10, 2022CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
MaldivesPresidency of the MaldivesMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
MaliWorld Health OrganizationMar. 4, 2022Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaAfrica Centres for Disease Control and PreventionMar. 10, 2022Oxford/AstraZeneca, Sinopharm/Beijing
MauritiusWorld Health OrganizationMar. 10, 2022Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
MexicoSecretary of HealthMar. 9, 2022CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MonacoNational CouncilDec. 21, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontenegroGovernment of MontenegroMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontserratWorld Health OrganizationFeb. 25, 2022Oxford/AstraZeneca
MoroccoWorld Health OrganizationMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MozambiqueWorld Health OrganizationMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MyanmarWorld Health OrganizationMar. 8, 2022Oxford/AstraZeneca, Sinopharm/Beijing
NamibiaAfrica Centres for Disease Control and PreventionFeb. 25, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
NauruWorld Health OrganizationJan. 18, 2022Oxford/AstraZeneca
NepalWorld Health OrganizationMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
NetherlandsEuropean CDC, via Marino van ZelstMar. 5, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
New CaledoniaSPC Public Health DivisionMar. 7, 2022Pfizer/BioNTech
New ZealandMinistry of HealthMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech
NicaraguaWorld Health OrganizationMar. 9, 2022Abdala, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Soberana02, Sputnik Light, Sputnik V
NigerWorld Health OrganizationFeb. 26, 2022Oxford/AstraZeneca, Sinopharm/Beijing
NigeriaWorld Health OrganizationMar. 6, 2022Oxford/AstraZeneca
NiueSPC Public Health DivisionNov. 24, 2021Pfizer/BioNTech
North MacedoniaGovernment of North MacedoniaFeb. 27, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Northern CyprusMinistry of HealthNov. 26, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthMar. 9, 2022Moderna, Pfizer/BioNTech
OmanWorld Health OrganizationFeb. 28, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
PakistanNational Command and Operation CentreMar. 10, 2022CanSino, Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Palestine (see FAQ)World Health OrganizationMar. 6, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PanamaPan American Health OrganizationMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Papua New GuineaSPC Public Health DivisionMar. 7, 2022Oxford/AstraZeneca
ParaguayPan American Health OrganizationMar. 4, 2022Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
PeruMinisterio de Salud via github.com/jmcastagnetto/covid-19-peru-vacunasMar. 8, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesDepartment of Health via ABS-CBN Investigative and Research GroupFeb. 27, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PitcairnSPC Public Health DivisionSep. 7, 2021Oxford/AstraZeneca
PolandMinistry of HealthMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalDirectorate General for Health via Data Science for Social GoodMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
QatarMinistry of Public HealthMar. 10, 2022Moderna, Pfizer/BioNTech
RomaniaGovernment of Romania via datelazi.roMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruMar. 10, 2022EpiVacCorona, Sputnik V
RwandaWorld Health OrganizationMar. 10, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Saint HelenaGovernment of Saint HelenaMay. 5, 2021Oxford/AstraZeneca
Saint Kitts and NevisPan American Health OrganizationFeb. 25, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Saint LuciaMinistry of HealthMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech
Saint Vincent and the GrenadinesMinistry of HealthMar. 9, 2022Oxford/AstraZeneca
SamoaSPC Public Health DivisionFeb. 21, 2022Oxford/AstraZeneca
San MarinoWorld Health OrganizationFeb. 20, 2022Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeWorld Health OrganizationMar. 10, 2022Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilFeb. 15, 2022Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SenegalWorld Health OrganizationMar. 1, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
SerbiaGovernment of SerbiaMar. 9, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesWorld Health OrganizationMar. 10, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Sierra LeoneWorld Health OrganizationMar. 4, 2022Oxford/AstraZeneca, Sinopharm/Beijing
SingaporeGovernment of SingaporeMar. 7, 2022Moderna, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
Sint Maarten (Dutch part)World Health OrganizationFeb. 25, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SlovakiaMinistry of HealthMar. 6, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
SloveniaNational Institute of Public Health via covid-19.sledilnik.orgMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsSPC Public Health DivisionMar. 7, 2022Oxford/AstraZeneca
SomaliaWorld Health OrganizationFeb. 28, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
South AfricaMinistry of HealthMar. 10, 2022Johnson&Johnson, Pfizer/BioNTech
South KoreaKorea Centers for Disease Control and PreventionMar. 10, 2022Johnson&Johnson, Moderna, Novavax, Oxford/AstraZeneca, Pfizer/BioNTech
South SudanWorld Health OrganizationFeb. 20, 2022Johnson&Johnson, Oxford/AstraZeneca
SpainMinistry of HealthMar. 3, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health’s Epidemiology UnitMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SudanWorld Health OrganizationFeb. 17, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
SurinameGovernment of SurinameMar. 6, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
SwedenPublic Health Agency of SwedenMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthMar. 9, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
SyriaWorld Health OrganizationMar. 1, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
TaiwanTaiwan Centers for Disease ControlMar. 10, 2022Medigen, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
TajikistanWorld Health OrganizationFeb. 20, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
TanzaniaWorld Health OrganizationFeb. 23, 2022Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing
ThailandGovernment of ThailandMar. 10, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
TimorWorld Health OrganizationMar. 1, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
TogoWorld Health OrganizationMar. 4, 2022Oxford/AstraZeneca
TokelauSPC Public Health DivisionOct. 12, 2021Pfizer/BioNTech
TongaSPC Public Health DivisionFeb. 28, 2022Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthMar. 10, 2022Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
TunisiaMinistry of HealthMar. 9, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformMar. 10, 2022Pfizer/BioNTech, Sinovac, Turkovac
TurkmenistanWorld Health OrganizationAug. 29, 2021EpiVacCorona, Oxford/AstraZeneca, QazVac, Sinopharm/Beijing, Sputnik V, ZF2001
Turks and Caicos IslandsWorld Health OrganizationFeb. 25, 2022Pfizer/BioNTech
TuvaluWorld Health OrganizationOct. 22, 2021Oxford/AstraZeneca
UgandaWorld Health OrganizationFeb. 28, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UkraineMinistry of HealthFeb. 23, 2022Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V
United KingdomGovernment of the United KingdomMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionMar. 9, 2022Johnson&Johnson, Moderna, Pfizer/BioNTech
UruguayMinistry of Health via vacuna.uyMar. 10, 2022Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UzbekistanWorld Health OrganizationFeb. 20, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik Light, Sputnik V, ZF2001
VanuatuSPC Public Health DivisionFeb. 28, 2022Oxford/AstraZeneca
VenezuelaPan American Health OrganizationFeb. 25, 2022Abdala, Sinopharm/Beijing, Sinovac, Soberana02, Sputnik Light, Sputnik V
VietnamWorld Health OrganizationMar. 9, 2022Abdala, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
WalesGovernment of the United KingdomMar. 9, 2022Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Wallis and FutunaSPC Public Health DivisionFeb. 28, 2022Moderna
YemenWorld Health OrganizationMar. 6, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinovac
ZambiaGovernment of ZambiaMar. 9, 2022Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
ZimbabweMinistry of HealthMar. 10, 2022Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V

Frequently-asked questions

Why do the figures displayed on this page look different from the ones published by my government?

In some cases, the vaccination figures on this page can look different from the ones reported by governments. Most often it is not because of the numerator (number of people vaccinated) but instead because of the denominator (number of people in the population). This usually happens for two main reasons:

  1. The official data reports the vaccination coverage in terms of the share of people vaccinated in the population eligible for vaccination (very often, among adults only). Our priority is to make our data comparable between countries — regardless of criteria for eligibility, which tend to vary across countries and across time. For this reason, we always use the total population of the country (i.e. people of all ages) as the denominator.
  2. The official data uses a different population estimate. The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier (see below for more information). In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.
What population data are the per-capita metrics based on?

The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier. The exact values can be viewed in our GitHub repository.

The United Nations estimates may not always reflect the latest censuses or national figures—but there are several reasons why we use this data over country-by-country national population estimates.

  • The UNWPP dataset is the standard in research. The main reason is that it uses a reliable and standardized methodology for all countries. For example, if we used individual country data, some may include overseas workers, expats, undocumented immigrants, etc. but others wouldn’t.
  • Using data from the UN allows us to get accurate population estimates for all territories in the world very easily. Finding and maintaining estimates based on national censuses would be very time-consuming for our small team, without bringing much additional value to our work.
  • Other reasons include the availability of yearly data (national censuses are only conducted every few years), and avoiding double-counting in cases of border disputes.

For all these reasons, the UN data is the best solution to bring accurate per-capita metrics to our COVID data. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.

Can the value of per-capita metrics exceed 100%?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates. Additionally, it’s important to bear in mind that in some territories, vaccination coverage may include non-residents (such as tourists and foreign workers). For these reasons, per-capita metrics may sometimes exceed 100%.

What is the definition of a complete initial protocol?

In our data, people with a complete initial protocol are those who have received all doses prescribed by their vaccination regimen (e.g. 2 doses for Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, etc. and 1 dose for Johnson & Johnson, CanSino, etc.).

Some countries also allow for alternative definitions, such as having been infected with SARS-CoV-2 in the past and having received 1 dose of a two-dose regimen. We currently ignore these alternative definitions to preserve the common definition of a complete protocol, i.e. all doses required in the vaccine regimen. This allows for optimal comparability between countries.

What classification are the income groups based on?

The income groups we use come from the World Bank income classification. The exact list of countries can be viewed in our GitHub repository.

Why isn’t my country shown by default on a chart? How do you choose which countries are shown?

Due to the limited space on our charts and the number of countries in the world, unfortunately, we cannot show every country in the world by default. On each chart of this page, therefore we choose a default selection of countries based on a mix of criteria: mainly total population, but also the number of doses administered and share of the population vaccinated. These lists are updated about once a month.

Are participants in vaccine clinical trials included in your data?

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

How do you report vaccinations performed in Israel and Palestine?

In our dataset and charts on COVID-19 vaccinations, we report vaccinations performed in Israel and Palestine separately.

The vaccination data is needed to understand how the pandemic is evolving. For this, it is key to bring together the vaccination data with data on COVID-19 cases and COVID-19 deaths. Global health institutions that report on the pandemic are reporting these metrics separately: 

  • The World Health Organization reports the measures for Israel separately from Palestine in its data.
  • Johns Hopkins University also reports Israel separately from Palestine in its data on cases & deaths of COVID-19, which has been used worldwide in the last year.

Reporting the data for Palestine and Israel separately also allows us to show their respective reported vaccination levels. It makes clear what the respective vaccination levels are, as reported by the Government of Israel and the Palestinian Ministry of Health.

Finally, our dataset on COVID-19 vaccinations is sourced from official data published by governments and ministries of health from countries around the world. This is also the case for Israel and Palestine. We show figures for Palestine and Israel separately, as they are reported separately by the Government of Israel and the Palestinian Ministry of Health

The Populations Division of the United Nations reports population figures for countries around the world, and we are relying on their latest data (from their 2019 revision) for countries around the world of. They report a population of 8,655,541 people for Israel and a population of 5,101,416 people for Palestine.

The resulting shares of people vaccinated in Israel and Palestine can be seen in our COVID-19 Data Explorer.


Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with our work on COVID-19, and the many other topics we cover you can sign up for our newsletter.

Research and data: Hannah Ritchie, Esteban Ortiz-Ospina, Diana Beltekian, Edouard Mathieu, Joe Hasell, Bobbie Macdonald, Charlie Giattino, Cameron Appel, Lucas Rodés-Guirao and Max Roser
Web development: Ernst van Woerden, Daniel Gavrilov, Matthieu Bergel, Jason Crawford, and Marcel Gerber

None selected